IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enavate Sciences GP, LLC

Q4 2024 Holdings

Filed 2025-02-14 | 5 holdings | $139.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Upstream BIO Inc(UPB)COM91678A107$40.4M2,459,70329.0%
Immunome Inc(IMNM)COM45257U108$36.9M3,478,26126.5%
Zenas Biopharma Inc(ZBIO)COM98937L105$30.8M3,761,35922.1%
Camp4 Therapeutics Corp(CAMP)COM13463J101$19.8M3,785,80214.2%
Compass Therapeutics Inc(CMPX)COM20454B104$11.3M7,788,1508.1%